CompletedNot Applicable

Energy Expenditure of People Living With HIV/AIDS

45 participantsStarted 2013-03

Plain-language summary

Background: Several studies have reported increased resting energy expenditure (REE) in people living with HIV/AIDS possibly due to changes in body composition that occurs in HIV lipodystrophy syndrome. The aim of this study was to evaluate the influence of the use of lipid-lowering drugs in resting energy expenditure (REE) and total energy expenditure (TEE) in patients seropositive for HIV in treatment of lipodystrophy.

Who can participate

Age range18 Years – 60 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Use of antiretroviral therapy for at least 4 months * A cluster of differentiation 4 (CD4) T-cell count of \>200 cells/mm3 * Use of lipid-lowering drugs for at least 1 month (group HIV-seropositive with lipodystrophy and use of lipid-lowering) Exclusion Criteria: * Signs or symptoms of opportunistic infections * Thyroid disease

What they're measuring

Total Energy Expenditure (kcal/d)

Timeframe: 14 day

Resting Energy Expenditure (kcal/d)

Timeframe: 1 day

Trial details

NCT IDNCT02530827

SponsorUniversity of Sao Paulo General Hospital

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2014-06

View on ClinicalTrials.gov More HIV/AIDS trials